Company intelligence / Profile preview
Mitra Biotech
Woburn, MA, USAdrugtargetreview.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Mitra Biotech develops the CANscript™ ex vivo tumor microenvironment modeling system that predicts individual patient responses to cancer therapies. This enables more effective personalized treatment selection and accelerates oncology drug development. Their technology has shown strong correlation with actual patient outcomes. They collaborate globally—including partnerships with Brigham and Women’s Hospital—to advance next-generation immunotherapies such as engineered oncolytic viruses for brain tumors like glioblastoma multiforme.
- Therapeutic areas
- Oncology
- Modalities
- Oncolytic virus therapySmall moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Brigham and Women’s Hospital / Harvard Medical School Department of Neurosurgery—for evaluation of novel engineered HSV‑1-based oncolytic viruses in GBM patients using the CANscript™ platform
Beyond the preview
Go deeper on Mitra Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mitra Biotech.